A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Clinical trial NCT04046549 · COMPLETED

Trial details

NCT number: NCT04046549
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allografts Rejection; Transplant, Kidney Transplant Rejection Kidney Transplantation

Start date: 2019-10-30
Primary completion: 2022-07-18
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.